5-Fluorouracil augmentation of dihydrofolate reductase RNA containing contiguous exon and intron sequences in KB7B cells.
Quantitative S1 nuclease mapping studies were performed with uniformly labeled RNA probes, containing contiguous dihydrofolate reductase exon and intron sequences, and total RNA isolated from KB7B cells exposed to 5-fluorouracil for 5 days. Dihydrofolate reductase RNA containing both exon 1 and intron I, or exon 5 and a portion of intron V, increased up to 5-fold in cells grown in the presence of 2.0 to 3.0 microM 5-fluorouracil. Dihydrofolate reductase RNA containing exon 1 or exon 5, but lacking intron I or intron V, respectively, increased 2-fold in cells grown in the presence of 0.65 to 3.0 microM 5-fluorouracil. Primer extension analysis and S1 mapping studies revealed two major transcriptional start sites at positions -72 and -69 and minor start sites upstream from position -183, for dihydrofolate reductase RNA isolated from methotrexate-resistant KB7B cells. The results of these studies demonstrate that 5-fluorouracil alters the metabolism of dihydrofolate reductase precursor mRNA and/or processing intermediates.
D004720:Endonucleases; D005091:Exons / Q000187:drug effects*; D005472:Fluorouracil / Q000494:pharmacology*; D006801:Humans; D007438:Introns / Q000187:drug effects*; D007624:KB Cells; D009694:Nucleic Acid Precursors / Q000235:genetics; D009710:Nucleotide Mapping; D012322:RNA Precursors; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics*; D015719:Single-Strand Specific DNA and RNA Endonucleases; D013762:Tetrahydrofolate Dehydrogenase / Q000235:genetics*
D009694:Nucleic Acid Precursors; D012322:RNA Precursors; D012333:RNA, Messenger; D013762:Tetrahydrofolate Dehydrogenase; D004720:Endonucleases; D015719:Single-Strand Specific DNA and RNA Endonucleases; D005472:Fluorouracil